Stock SUPN SUPERNUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Supernus Pharmaceuticals, Inc.

Equities

SUPN

US8684591089

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
27.15 USD -1.42% Intraday chart for Supernus Pharmaceuticals, Inc. +2.18% -6.19%
May. 23 Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study MT
May. 23 Transcript : Supernus Pharmaceuticals, Inc. - Special Call

Transcripts

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Transcript : Supernus Pharmaceuticals, Inc. - Special Call
Transcript : Supernus Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024
Transcript : Supernus Pharmaceuticals, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 03:35 PM
Transcript : Supernus Pharmaceuticals, Inc., Q4 2023 Earnings Call, Feb 27, 2024
Transcript : Supernus Pharmaceuticals, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Transcript : Supernus Pharmaceuticals, Inc. - Special Call
Transcript : Supernus Pharmaceuticals, Inc., Q2 2023 Earnings Call, Aug 08, 2023
Transcript : Supernus Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 09, 2023
Transcript : Supernus Pharmaceuticals, Inc., Q4 2022 Earnings Call, Feb 28, 2023
Transcript : Supernus Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 08, 2022
Transcript : Supernus Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 04, 2022
Supernus Pharmaceuticals, Inc. Provides Earning Guidance for Full Year 2022
CI
Supernus Pharmaceuticals, Inc. Reiterates Earnings Guidance for the Full Year 2022
CI
Transcript : Supernus Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 09, 2022
Supernus Pharmaceuticals, Inc. Reiterates Earnings Guidance for the Year 2022
CI
Transcript : Supernus Pharmaceuticals, Inc., Q4 2021 Earnings Call, Feb 28, 2022
Supernus Pharmaceuticals, Inc. Provides Earnings Guidance for the Full Year of 2022
CI
Transcript : Supernus Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 03, 2021
Transcript : Adamas Pharmaceuticals, Inc., Supernus Pharmaceuticals, Inc. - M&A Call
Transcript : Supernus Pharmaceuticals, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-15-2021 11:45 AM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SUPN Stock
  4. News Supernus Pharmaceuticals, Inc.
  5. Transcripts